Anti-snoring Treatment Market 2019
Snoring is noisy breathing during sleep that affects most people when the turbulent air flows through the upper airway causing the uvula and soft palate to vibrate. It is usually harmless but habitual snoring can cause some adverse health issues that, in turn, will need the anti-snoring treatment. Snoring is a treatable condition but obesity, smoking, drinking, or nasal congestion increases the risk of snoring related problems. The thickening of walls of carotid arteries that carry blood to the brain can lead to such problems, which can result in an increased risk of stroke.
For more information or any query mail at email@example.com
Listed Key Players
Some significant competitors of the anti-snoring devices and snoring surgery market include Apnea Sciences Corporation, Pure Sleep Company, SomnoMed Ltd., Airway Management, Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, GlaxoSmithKline Plc, and Meditas Ltd., among others.
The anti-snoring treatment includes the non-surgical snoring treatments, using devices like special pillows, dental bites and chin straps. It also includes laser snoring and radiofrequency treatments that are least invasive and provide less postoperative discomfort. These latest methods are widely popular among patients dealing with snoring problems. The increasing consumption of alcohol and cigarettes is ensuing health dangers and diseases, such as snoring, sleep apnea, interference in breathing and strain on the heart, to an undiscovered population pool, especially the geriatric and obsessed population.
As per the global anti-snoring treatment market report, the market was valued at US$ 1,006.56 million in 2018 and is expected to reach US$1,842.33 million by the end of 2024, prospering with a CAGR of 10.60%. The anti-snoring devices are increasing mindfulness in the developed markets and are acting as the key components responsible for the growth of the anti-snoring treatment market. Obesity is a noteworthy contributor to snoring, where the elder population is mostly affected by this problem. According to the National Sleep Foundation, in 2017, snoring influenced 90 million adults and 37 million of these face snoring on a regular basis.
The non-surgical appliances and choices, the overrated medical expenses and the limited availability of anti-snoring related medicines are some of the factors leading to the development of the anti-snoring devices and treatment.
The global anti-snoring treatment market by type for the period 2017-2027 has been split into:
Laser-Assisted Uvulopalatoplasty (Laup)
Radiofrequency Ablation (Somnoplasty)
The anti-snoring treatment devices include Mandibular progression devices (MAD), tongue stabilizing devices (TSD), continuous positive aviation route weight (CPAP) devices, and nasal devices, among others. The CPAP devices category is believed to hold the biggest market share and will observe a CAGR of 10.54% as mentioned in the report.
The major countries like Canada, the U.S., Germany, UK, India, China, Brazil, South Africa and Mexico are analysed in the global product meet report, where the U.S. dominates the overall market. In 2015, Europe was the second-largest regional market for anti-snoring treatment and the increased popularity and high selection choice of the treatment devices has contributed to the development of the product in this area. The Asia-Pacific regional market is expected to register considerable growth due to the presence of a large number of untreated patients with the snoring condition. According to the American Academy of Sleep Medicine (AASM), 29.4 million US residents have obstructive sleep apnea that leads to the snoring problem. The technological advancements and creations that are continuously being developed are progressively helpful to the patients. In addition to sleep apnea, the obese population has tripled between 1975 and 2016. The WHO estimated, more than 1.9 billion adults were overweight and more than 650 million people were in the obese category, which has led to the positive growth of the anti-snoring treatment market.
Sunderland-based Ashford Orthodontics has signed a deal with ProSomnus Sleep Technologies, an American company for sleep apnoea therapy devices, to bring the ProSomnus devices to the UK and Ireland. The obstructive sleep apnoea affects a lot of people where the blockage in the airway is caused during sleep, causing the narrowing or complete closure of air passages leading to heavy snoring.
Table of Contents – Major Key Points
Chapter 1 OVERVIEW AND SCOPE
Chapter 2 Executive Summary
Chapter 3 Market Insights
Chapter 4 Industry Trends
Chapter 5 Global Anti-snoring Treatment Market Analysis, by Type, 2017 – 2027 (US$ Bn)
Chapter 6 North America Anti-snoring Treatment Market Analysis, 2017 – 2027 (US$ Bn)
Chapter 7 Europe Anti-snoring Treatment Market Analysis, 2017 – 2027 (US$ Bn)
Chapter 8 Asia Pacific Anti-snoring Treatment Market Analysis, 2017 – 2027 (US$ Bn)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349